CLEC11A and osteoporosis: Another intriguing study demonstrated that MSC-EVs loaded with recombinant C-Type lectin domain family 11, member A (CLEC11A) facilitate the transition of BM-MSC from lipogenic to osteogenic differentiation and inhibit osteoclast activity, ultimately alleviating osteoporosis [73].